{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:49:05Z","timestamp":1792187345004,"version":"4.4.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jaci.2025.10.023","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T16:42:11Z","timestamp":1762274531000},"page":"38-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["A promise fulfilled: Updates on respiratory syncytial virus vaccines and monoclonal antibodies"],"prefix":"10.1016","volume":"157","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7505-3014","authenticated-orcid":false,"given":"Alastair","family":"Murray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen Y.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2025.10.023_bib1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.coviro.2017.03.012","article-title":"Vaccine development for respiratory syncytial virus","volume":"23","author":"Graham","year":"2017","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.jaci.2025.10.023_bib2","article-title":"Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors","volume":"16","author":"Gilman","year":"2016","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2025.10.023_bib3","doi-asserted-by":"crossref","first-page":"920","DOI":"10.15585\/mmwr.mm7234a4","article-title":"Use of nirsevimab for the prevention of respiratory syncytial virus disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2023","volume":"25","author":"Jones","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaci.2025.10.023_bib4","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa043951","article-title":"Respiratory syncytial virus infection in adults","volume":"352","author":"Falsey","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.10.023_bib5","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/jamainternmed.2024.0212","article-title":"Acute cardiac events in hospitalized older adults with respiratory syncytial virus infection","volume":"184","author":"Woodruff","year":"2024","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jaci.2025.10.023_bib6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/infdis\/jiaa331","article-title":"Epidemiology of respiratory syncytial virus across five influenza seasons among adults and children one year of age and older\u2014Washington State, 2011\/2012-2015\/2016","volume":"4","author":"Jackson","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2025.10.023_bib7","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/cid\/ciae085","article-title":"Clinical characteristics, and outcomes of respiratory syncytial virus disease by subtype among children aged <5 years: new vaccine surveillance network, United States, 2016-2020","volume":"15","author":"Toepfer","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2025.10.023_bib8","first-page":"195","article-title":"The effects of the COVID-19 pandemic on community respiratory virus activity","volume":"21","author":"Chow","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jaci.2025.10.023_bib9","article-title":"Household transmission and genomic diversity of respiratory syncytial virus (RSV) in the United States, 2022-2023","author":"Cox","year":"2025","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2025.10.023_bib10","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0022-3476(81)80829-3","article-title":"Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level","volume":"98","author":"Glezen","year":"1981","journal-title":"J Pediatr"},{"issue":"210","key":"10.1016\/j.jaci.2025.10.023_bib11","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/infdis\/jiu316","article-title":"Respiratory syncytial virus transplacental antibody transfer and kinetics in mother\u2013infant pairs in Bangladesh","volume":"15","author":"Chu","year":"2014","journal-title":"J Infect Dis"},{"issue":"219","key":"10.1016\/j.jaci.2025.10.023_bib12","first-page":"59","article-title":"Breast milk prefusion F immunoglobulin G as a correlate of protection against respiratory syncytial virus acute respiratory illness","volume":"1","author":"Mazur","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2025.10.023_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2025.110395","article-title":"Review of impaired immune parameters in RSV infections in the elderly","volume":"603","author":"Miller","year":"2025","journal-title":"Virology"},{"key":"10.1016\/j.jaci.2025.10.023_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.105823","article-title":"Unmasking the potential of secretory IgA and its pivotal role in protection from respiratory viruses","volume":"223","author":"Sinha","year":"2024","journal-title":"Antiviral Res"},{"issue":"200","key":"10.1016\/j.jaci.2025.10.023_bib15","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1164\/rccm.201812-2366OC","article-title":"Elevated levels of type 2 respiratory innate lymphoid cells in human infants with severe respiratory syncytial virus bronchiolitis","volume":"1","author":"Vu","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"168","key":"10.1016\/j.jaci.2025.10.023_bib16","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1164\/rccm.200210-1148OC","article-title":"Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis","volume":"15","author":"Legg","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"44","key":"10.1016\/j.jaci.2025.10.023_bib17","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2500\/aap.2023.44.230030","article-title":"The third pandemic: the respiratory syncytial virus landscape and specific considerations for the allergist\/immunologist","volume":"26","author":"Frenkel","year":"2023","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2025.10.023_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12026-014-8540-1","article-title":"The CD4 T cell response to respiratory syncytial virus infection","volume":"59","author":"Christiaansen","year":"2014","journal-title":"Immunol Res"},{"key":"10.1016\/j.jaci.2025.10.023_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1025341","article-title":"Prior respiratory syncytial virus infection reduces vaccine-mediated Th2-skewed immunity, but retains enhanced RSV F-specific CD8 T cell responses elicited by a Th1-skewing vaccine formulation","volume":"13","author":"Eichinger","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.10.023_bib20","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2557676","article-title":"Safety and immunogenicity of an mRNA-based RSV vaccine in seropositive children aged 12-59 months","volume":"21","author":"Schnyder Ghamloush","year":"2025","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jaci.2025.10.023_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11882-025-01194-w","article-title":"Burden of respiratory syncytial virus disease in adults with asthma and chronic obstructive pulmonary disease: a systematic literature review","volume":"25","author":"Penders","year":"2025","journal-title":"Curr Allergy Asthma Rep"},{"issue":"10379","key":"10.1016\/j.jaci.2025.10.023_bib22","first-page":"1127","article-title":"Medically attended RSV infection during infancy and subsequent risk of childhood asthma","volume":"401","author":"Rosas-Salazar","year":"2023","journal-title":"Lancet"},{"issue":"196","key":"10.1016\/j.jaci.2025.10.023_bib23","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1086\/520886","article-title":"Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes","volume":"15","author":"Janssen","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2025.10.023_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.998296","article-title":"An overview on the RSV-mediated mechanisms in the onset of non-allergic asthma","volume":"10","author":"Manti","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaci.2025.10.023_bib25","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jaci.2016.01.050","article-title":"Respiratory syncytial virus infection activates IL-13\u2013producing group 2 innate lymphoid cells through thymic stromal lymphopoietin","volume":"824","author":"Stier","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.023_bib26","first-page":"1580","article-title":"Maternal RSV prefusion F protein vaccine in pregnant women","volume":"388","author":"Polack","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.10.023_bib27","author":"DeSilva"},{"key":"10.1016\/j.jaci.2025.10.023_bib28","author":"P\u00e9rez Marc","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jaci.2025.10.023_bib29","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa2305478","article-title":"Safety of RSV maternal vaccine and risk of preterm birth","volume":"390","author":"Dieussaert","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.10.023_bib30","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.19268","article-title":"Nonadjuvanted bivalent respiratory syncytial virus vaccination and perinatal outcomes","volume":"7","author":"Son","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaci.2025.10.023_bib31","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/s41591-023-02316-5","article-title":"Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants","volume":"29","author":"Wilkins","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2025.10.023_bib32","doi-asserted-by":"crossref","first-page":"508","DOI":"10.15585\/mmwr.mm7432a3","article-title":"Use of clesrovimab for prevention of severe respiratory syncytial virus\u2013associated lower respiratory tract infections in infants: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2025","volume":"74","author":"Moulia","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"231","key":"10.1016\/j.jaci.2025.10.023_bib33","doi-asserted-by":"crossref","first-page":"e478","DOI":"10.1093\/infdis\/jiae581","article-title":"A phase 1b\/2a trial of a half-life extended respiratory syncytial virus neutralizing antibody, clesrovimab, in healthy preterm and full-term infants","volume":"17","author":"Madhi","year":"2025","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2025.10.023_bib34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.15585\/mmwr.mm7309a4","article-title":"Early estimate of nirsevimab effectiveness for prevention of respiratory syncytial virus\u2013associated hospitalization among infants entering their first respiratory syncytial virus season\u2014new vaccine surveillance network, October 2023-February 2024","volume":"73","author":"Moline","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaci.2025.10.023_bib35","article-title":"Safety of nirsevimab in infants: data from a second RSV season","volume":"13","author":"Dagan","year":"2024","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.jaci.2025.10.023_bib37","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2024-066508","article-title":"Safety and pharmacokinetics of nirsevimab in immunocompromised children","volume":"154","author":"Domachowske","year":"2024","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2025.10.023_bib38","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2209604","article-title":"Respiratory syncytial virus prefusion F protein vaccine in older adults","volume":"388","author":"Papi","year":"2023","journal-title":"N Engl J Med"},{"issue":"388","key":"10.1016\/j.jaci.2025.10.023_bib39","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMoa2213836","article-title":"Efficacy and safety of a bivalent RSV prefusion F vaccine in older adults","volume":"20","author":"Walsh","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.10.023_bib40","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa2307079","article-title":"Efficacy and safety of an mRNA-based RSV PreF vaccine in older adults","volume":"389","author":"Wilson","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.10.023_bib41","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/cid\/ciae010","article-title":"Efficacy and safety of respiratory syncytial virus (RSV) prefusion F protein vaccine (RSVPreF3 OA) in older adults over 2 RSV seasons","volume":"78","author":"Ison","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2025.10.023_bib42","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2025.15896","article-title":"RSV vaccine effectiveness against hospitalization among US adults aged 60 years or older during 2 seasons","author":"Surie","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2025.10.023_bib43","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2025.16705","article-title":"Shot through the heart\u2014can RSV vaccination reduce risk of cardiovascular outcomes?","author":"Chu","year":"2025","journal-title":"JAMA"},{"issue":"73","key":"10.1016\/j.jaci.2025.10.023_bib44","doi-asserted-by":"crossref","first-page":"489","DOI":"10.15585\/mmwr.mm7321a3","article-title":"Early safety findings among persons aged \u226560 years who received a respiratory syncytial virus vaccine\u2014United States, May 3, 2023-April 14, 2024","volume":"30","author":"Hause","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaci.2025.10.023_bib45","article-title":"Safety and immunogenicity of bivalent RSVpreF vaccine coadministered with seasonal inactivated influenza vaccine in older adults","author":"Athan","year":"2025","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2025.10.023_bib46","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s40121-025-01135-0","article-title":"Optimal timing of vaccination: a narrative review of integrating strategies for COVID-19, influenza, and respiratory syncytial virus","volume":"14","author":"Bonanni","year":"2025","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.jaci.2025.10.023_bib47","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae550","article-title":"Bivalent RSVpreF vaccine in adults 18 to <60 years old with high-risk conditions","author":"Davis","year":"2025","journal-title":"Clin Infect Dis"},{"issue":"333","key":"10.1016\/j.jaci.2025.10.023_bib48","first-page":"429","article-title":"Antibody response to respiratory syncytial virus vaccination in immunocompromised persons","volume":"4","author":"Karaba","year":"2024","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.jaci.2025.10.023_bib50","article-title":"Effectiveness and safety of respiratory syncytial virus vaccine for US adults aged 60 years or older","volume":"1","author":"Fry","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaci.2025.10.023_bib51","doi-asserted-by":"crossref","first-page":"e747","DOI":"10.1016\/S1473-3099(24)00455-9","article-title":"The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access","volume":"24","author":"Terstappen","year":"2024","journal-title":"Lancet Infect Dis"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925011133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925011133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:00:09Z","timestamp":1789174809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674925011133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0091674925011133"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2025.10.023","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A promise fulfilled: Updates on respiratory syncytial virus vaccines and monoclonal antibodies","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2025.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}